Novartis announced disappointing sales for a key psoriasis drug and the looming retirement of its respected finance chief, which overshadowed a modest outlook raise. Novartis CEO Vasant Narasimham speaks with Bloomberg's Scarlet Fu on the impact of pharma tariffs.

Novartis announced disappointing sales for a key psoriasis drug and the looming retirement of its respected finance chief, which overshadowed a modest outlook raise. Novartis CEO Vasant Narasimham speaks with Bloomberg's Scarlet Fu on the impact of pharma tariffs.

Listen for top interviews from Bloomberg News. 

Hear conversations with the biggest names in finance, politics, technology, foreign relations, sports and entertainment.

Listen for top interviews from Bloomberg News. Hear conversations with the biggest names in finance, politics, technology, foreign relations, sports and entertainment.

Listen to top interviews from Bloomberg News.

Bloomberg Talks

Novartis CEO Vas Narasimhan Talks Psoriasis Drug, China Growth, M&A

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/30c9cbcb-02f8-438f-90e7-b31d014d51ef/transcript

Wells Fargo Chief Executive Officer Charlie Scharf says he's "big time bullish on the US." He talks about the state of the US consumer, the economy, earnings and where his employees want to live and work. He speaks exclusively to Bloomberg's Romaine Bostick.

Wells Fargo Chief Executive Officer Charlie Scharf says he's "big time bullish on the US." He talks about the state of the US consumer, the economy, earnings and where his employees want to live and work. He speaks exclusively to Bloomberg's Romaine Bostick.

Wells Fargo CEO Charlie Scharf Talks Economy, US Consumer, Earnings

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/f43df14c-ddfb-433e-9258-b48f00ee4621/transcript

AT&T Chairman & CEO John Stankey says he believes the company's valuation will "ultimately correct itself" and that AT&T is positioned to be indispensable for future workloads in the AI environment, while speaking with Bloomberg News' Jonathan Ferro, Lisa Abramowicz and Annmarie Hordern on Bloomberg Surveillance. He also spoke about satellite and Starlink during the interview, saying SpaceX has served less densely populated areas.

AT&amp;T Chairman &amp; CEO John Stankey says he believes the company's valuation will "ultimately correct itself" and that AT&amp;T is positioned to be indispensable for future workloads in the AI environment, while speaking with Bloomberg News' Jonathan Ferro, Lisa Abramowicz and Annmarie Hordern on Bloomberg Surveillance. He also spoke about satellite and Starlink during the interview, saying SpaceX has served less densely populated areas.

 AT&T CEO John Stankey Talks Earnings

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/6bc4cdd7-28e1-4dd3-a2d2-b48f00eca4e6/transcript

Senator Mark Warner (D-VA) says Congress must move quickly to establish safeguards for artificial intelligence, warning that the technology could severely disrupt employment for recent college graduates. Warner also says he currently opposes the administration's supplemental funding request for the war with Iran and explains why he voted against Jay Clayton's nomination for director of national intelligence. He speaks with Joe Mathieu and Kailey Leinz on the late edition of Bloomberg's "Balance of Power."

Senator Mark Warner (D-VA) says Congress must move quickly to establish safeguards for artificial intelligence, warning that the technology could severely disrupt employment for recent college graduates. Warner also says he currently opposes the administration's supplemental funding request for the war with Iran and explains why he voted against Jay Clayton's nomination for director of national intelligence. He speaks with Joe Mathieu and Kailey Leinz on the late edition of Bloomberg's "Balance of Power."

Virginia Senator Mark Warner (D) Talks Risk of AI Taking Jobs

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/e9733777-d0b2-400c-8f2a-b48e017e0a78/transcript

Novartis CEO Vas Narasimhan Talks Psoriasis Drug, China Growth, M&A

In 1 playlist(s)

Bloomberg Talks

Social links

Follow podcast

Recent clips